Ultime notizie per Dana (NYSE:DAN) Azioni

Dana

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

Dana Inc

Danone SA

Dana Resources

DanCann Pharma AS

Danaher Corp

Danakali Ltd

Danakali Ltd ADR

Danam Health Holding Corp

Danaos Corp

DANAVATION TECHNOLOGIES by Danavation Technologies Corp.

Danavation Technologies Corp

DANIELI SVGS NON CONV by Danieli S.p.A.- Officine Meccaniche Danieli & C.

Danieli & C. Officine Meccaniche SpA

DANIELI OFFICINE UNSP/ADR by Danieli S.p.A.- Officine Meccaniche Danieli & C.

DANIELI OFFICINE UNS/ADR1 by Danieli S.p.A.- Officine Meccaniche Danieli & C.

DANIELS CORP ADVISOR by Daniels Corporate Advisory Co Inc

Daniels Corporate Advisory Co Inc

Danimer Scientific Inc

DANSKE BK AVS BEAR S/ADR by Danske Bank A/S

Danske Bank AS

DANSKE BK A/S BEARER SHS by Danske Bank A/S

News

Dana Announces Plan To Sell Off-Highway Business; Co. Also Initiates Cost Reduction Plan, Expecting To Deliver Annualized Savings Of ~$200M By 2026, Says Plans To Reduce Capital Spending To Reflect The Revised Market Demand For Electric Vehicles

Management

Dana Appoints Current Director R. Bruce McDonald As Chairman And CEO

During the last three months, 7 analysts shared their evaluations of Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>), revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $12.0, a high estimate of $16.00, and a low estimate of $7.00. This current average has decreased by 15.31% from the previous average price target of $14.17. 
<img src="https://www.benzinga.com/files/images/story/2024/1731344422_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Dana among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$14.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$7.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$14.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$9.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Edison Yu</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Hold</td>
<td>$12.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Dana. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Dana compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Dana's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Dana's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DAN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Dana analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Dana Better</h2>
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.
<h3>Financial Milestones: Dana's Journey</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: Dana's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -7.23%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 0.16%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 0.27%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Dana's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.05%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Dana's debt-to-equity ratio surpasses industry norms, standing at 2.02. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Unveiling 7 Analyst Insights On Dana

JP Morgan analyst Ryan Brinkman maintains Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) with a Overweight and lowers the price target from $16 to $14.

Price Target

JP Morgan Maintains Overweight on Dana, Lowers Price Target to $14

Wells Fargo analyst Colin Langan maintains Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) with a Underweight and lowers the price target from $9 to $7.

Wells Fargo Maintains Underweight on Dana, Lowers Price Target to $7

Barclays analyst Dan Levy maintains Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) with a Equal-Weight and lowers the price target from $14 to $12.

Barclays Maintains Equal-Weight on Dana, Lowers Price Target to $12

WIIM

Dana shares are trading lower after the company reported worse-than-expected Q3 financial results.

Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.23 by 47.83 percent. The company reported quarterly sales of $2.476 billion which missed the analyst consensus estimate of $2.589 billion by 4.38 percent. This is a 7.23 percent decrease over sales of $2.669 billion the same period last year.

Earnings

Earnings Misses

Dana Q3 2024 Adj. EPS $0.12 Misses $0.23 Estimate, Sales $2.476B Miss $2.589B Estimate

Shares of iRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) rose sharply in today's pre-market trading after the company announced that it was granted FDA clearance for its 510(k) submission related to prior design changes <a href="https://www.benzinga.com/quote/IRTC">made to the Zio AT device.</a>
iRhythm Technologies shares jumped 20.5% to $74.80 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Genprex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNPX#NASDAQ">GNPX</a>) rose 145.7% to $3.71 in pre-market trading after jumping around 260% on Monday.</li>
<li>SRM Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) gained 82.1% to $1.34 in pre-market trading.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) shares surged 77.5% to $4.03 in pre-market trading after declining 55% on Monday.</li>
<li>Urgent.ly Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULY#NASDAQ">ULY</a>) rose 44.5% to $0.9870 in pre-market trading.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares rose 42.2% to $0.47 in pre-market trading after jumping around 34% on Monday.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares jumped 39.1% to $0.2864 in pre-market trading after gaining around 15% on Monday.</li>
<li>MarketWise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTW#NASDAQ">MKTW</a>) gained 24.9% to $0.7315 in pre-market trading. MarketWise's 13G filing showed BlackRock reported a 5.2% stake in the co as of Sept. 30.</li>
<li>Addex Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) climbed 21.7% to $12.95 in pre-market trading.</li>
<li>Dana Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) gained 6.9% to $11.25 in pre-market trading after declining around 6% on Monday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>IN8bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INAB#NASDAQ">INAB</a>) shares dipped 21.3% to $0.3737 in pre-market trading after jumping around 75% on Monday.</li>
<li>GRI Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRI#NASDAQ">GRI</a>) shares fell 21.2% to $1.04 in pre-market trading after announcing exercise of warrants.</li>
<li>DMC Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) fell 18% to $10.60 in pre-market trading after the company cut its third-quarter guidance and announced it is no longer actively marketing DynaEnergetics and NobelClad.</li>
<li>Sensei Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) fell 15% to $0.6633 in today's pre-market trading after jumping over 78% on Monday.</li>
<li>Medpace Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) fell 11.3% to $313.00 in pre-market trading after the company reported worse-than-expected third-quarter sales results.</li>
<li>BioVie Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIVI#NASDAQ">BIVI</a>) shares fell 10.7% to $2.35 in pre-market trading. BioVie announced the pricing of registered direct offering and concurrent private placement priced at-the-market under Nasdaq rules.</li>
<li>Notable Labs, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTBL#NASDAQ">NTBL</a>) shares declined 9.3% to $0.3111 in pre-market trading after gaining over 10% on Monday.</li>
<li>Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) declined 9.2% to $130.00 in pre-market trading after reporting weak quarterly earnings.</li>
<li>Knightscope, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) shares declined 8.9% to $12.07 in pre-market trading after surging 19% on Monday.</li>
<li>ATN International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNI#NASDAQ">ATNI</a>) shares fell 8.1% to $29.30. ATN International will release third quarter results on Tuesday, Oct. 29.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41429862/this-analyst-with-85-accuracy-rate-sees-around-11-upside-in-netflix-here-are-5-stock-picks-for-last">This Analyst With 85% Accuracy Rate Sees Around 11% Upside In Netflix &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADXN

ATNI

BIVI

BOOM

ENSC

GNPX

ALPS ETF Trusthen & Steers Global Realty Majors ETF

INAB

IRTC

KSCP

MEDP

MKTW

NTBL

SNSE

TCBP

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

JP Morgan analyst Ryan Brinkman maintains Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) with a Overweight and lowers the price target from $17 to $16.

JP Morgan Maintains Overweight on Dana, Lowers Price Target to $16

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CZR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$45.00</td>
<td>$69.0K</td>
<td>6.5K</td>
<td>1.6K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$420.00</td>
<td>$27.7K</td>
<td>6.9K</td>
<td>1.1K</td>
</tr>
<tr>
<td>DAN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$11.00</td>
<td>$37.5K</td>
<td>1.1K</td>
<td>1.0K</td>
</tr>
<tr>
<td>LI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$30.00</td>
<td>$70.9K</td>
<td>11.3K</td>
<td>477</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$187.50</td>
<td>$25.3K</td>
<td>956</td>
<td>330</td>
</tr>
<tr>
<td>F</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$12.17</td>
<td>$32.0K</td>
<td>50.9K</td>
<td>283</td>
</tr>
<tr>
<td>SABR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$3.00</td>
<td>$33.3K</td>
<td>838</td>
<td>250</td>
</tr>
<tr>
<td>EDU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$70.00</td>
<td>$93.5K</td>
<td>185</td>
<td>209</td>
</tr>
<tr>
<td>CBRL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$45.00</td>
<td>$41.1K</td>
<td>425</td>
<td>209</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$80.00</td>
<td>$30.0K</td>
<td>1.8K</td>
<td>206</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For CZR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>), we notice a call option trade that happens to be neutral, expiring in 247 day(s) on June 20, 2025. This event was a transfer of 100 contract(s) at a $45.00 strike. The total cost received by the writing party (or parties) was $69.0K, with a price of $690.0 per contract. There were 6516 open contracts at this strike prior to today, and today 1664 contract(s) were bought and sold. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a call option sweep that happens to be bearish, expiring in 93 day(s) on January 17, 2025. This event was a transfer of 550 contract(s) at a $420.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $27.7K, with a price of $50.0 per contract. There were 6972 open contracts at this strike prior to today, and today 1180 contract(s) were bought and sold. 
• For DAN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>), we notice a call option trade that happens to be bullish, expiring in 30 day(s) on November 15, 2024. This event was a transfer of 500 contract(s) at a $11.00 strike. The total cost received by the writing party (or parties) was $37.5K, with a price of $75.0 per contract. There were 1162 open contracts at this strike prior to today, and today 1000 contract(s) were bought and sold. 
• Regarding LI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), we observe a call option sweep with bullish sentiment. It expires in 93 day(s) on January 17, 2025. Parties traded 452 contract(s) at a $30.00 strike. This particular call needed to be split into 19 different trades to become filled. The total cost received by the writing party (or parties) was $70.9K, with a price of $157.0 per contract. There were 11385 open contracts at this strike prior to today, and today 477 contract(s) were bought and sold. 
• Regarding CVNA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>), we observe a call option sweep with bearish sentiment. It expires in 2 day(s) on October 18, 2024. Parties traded 35 contract(s) at a $187.50 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $25.3K, with a price of $725.0 per contract. There were 956 open contracts at this strike prior to today, and today 330 contract(s) were bought and sold. 
• For F (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), we notice a call option sweep that happens to be bullish, expiring in 93 day(s) on January 17, 2025. This event was a transfer of 1000 contract(s) at a $12.17 strike. This particular call needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $32.0K, with a price of $32.0 per contract. There were 50902 open contracts at this strike prior to today, and today 283 contract(s) were bought and sold. 
• For SABR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABR#NASDAQ">SABR</a>), we notice a call option trade that happens to be bullish, expiring in 429 day(s) on December 19, 2025. This event was a transfer of 249 contract(s) at a $3.00 strike. The total cost received by the writing party (or parties) was $33.3K, with a price of $134.0 per contract. There were 838 open contracts at this strike prior to today, and today 250 contract(s) were bought and sold. 
• For EDU (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>), we notice a put option trade that happens to be bearish, expiring in 30 day(s) on November 15, 2024. This event was a transfer of 199 contract(s) at a $70.00 strike. The total cost received by the writing party (or parties) was $93.5K, with a price of $470.0 per contract. There were 185 open contracts at this strike prior to today, and today 209 contract(s) were bought and sold. 
• Regarding CBRL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>), we observe a put option sweep with bearish sentiment. It expires in 30 day(s) on November 15, 2024. Parties traded 208 contract(s) at a $45.00 strike. This particular put needed to be split into 51 different trades to become filled. The total cost received by the writing party (or parties) was $41.1K, with a price of $202.0 per contract. There were 425 open contracts at this strike prior to today, and today 209 contract(s) were bought and sold. 
• Regarding SBUX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), we observe a put option trade with bullish sentiment. It expires in 156 day(s) on March 21, 2025. Parties traded 150 contract(s) at a $80.00 strike. The total cost received by the writing party (or parties) was $30.0K, with a price of $200.0 per contract. There were 1879 open contracts at this strike prior to today, and today 206 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

CBRL

CVNA

New Oriental Education & Technology Group

SABR

SBUX

TSLA

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

During the last three months, 6 analysts shared their evaluations of Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $13.5, a high estimate of $17.00, and a low estimate of $9.00. This current average represents a 8.78% decrease from the previous average price target of $14.80. 
<img src="https://www.benzinga.com/files/images/story/2024/1729026045_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Dana among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$14.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$9.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Edison Yu</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Hold</td>
<td>$12.00</td>
<td>-</td>
</tr>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Dana. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dana compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Dana's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Dana's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DAN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Dana analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Discovering Dana: A Closer Look</h2>
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.
<h3>Financial Insights: Dana</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Challenges: Dana's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.36%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 0.58%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.06%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Dana's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.2%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Dana's debt-to-equity ratio stands notably higher than the industry average, reaching 1.98. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Dana Through The Eyes Of 6 Analysts

Barclays analyst Dan Levy maintains Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) with a Equal-Weight and lowers the price target from $16 to $14.

Barclays Maintains Equal-Weight on Dana, Lowers Price Target to $14

Currently available at Dana facilities across Europe, the Dana Certified Reman&trade;&nbsp;program will extend to an additional 50 locations in&nbsp;North America, Europe, the&nbsp;Middle East,&nbsp;Africa, and&nbsp;China&nbsp;by the end of 2025.

Dana Says It Launched Dana Certified Reman Program Boosting Sustainability And Extending Life Cycles Of Drive Technologies For Off-highway

Dana (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dan#NYSE">DAN</a>) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The Zacks rating relies solely on a company&#39;s changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for Dana is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
<h2>Most Powerful Force Impacting Stock Prices</h2>
The change in a company&#39;s future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. That&#39;s partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company&#39;s shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Dana imply an improvement in the company&#39;s underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
<h2>Harnessing the Power of Earnings Estimate Revisions</h2>
Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
<h2>Earnings Estimate Revisions for Dana</h2>
For the fiscal year ending December 2024, this automotive equipment supplier is expected to earn $0.98 per share, which is a change of 16.7% from the year-ago reported number.
Analysts have been steadily raising their estimates for Dana. Over the past three months, the Zacks Consensus Estimate for the company has increased 34.2%.
<h2>Bottom Line</h2>
Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of &#39;buy&#39; and &#39;sell&#39; ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a &#39;Strong Buy&#39; rating and the next 15% get a &#39;Buy&#39; rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
The upgrade of Dana to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
<a href="https://www.zacks.com/stock/news/2340057/dana-dan-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2340057">To read this article on Zacks.com click here.</a>

Upgrades

Small Cap

Dana Upgraded to Buy: What Does It Mean for the Stock?

Wells Fargo analyst Colin Langan downgrades Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) from Equal-Weight to Underweight and lowers the price target from $13 to $9.

Downgrades

Wells Fargo Downgrades Dana to Underweight, Lowers Price Target to $9

ADNT

RIVN

Shares of auto-related stocks are trading higher following the Fed's policy decision to cut rates by 50 basis points, which could stimulate spending and enhance credit affordability.

Deutsche Bank analyst Edison Yu reinstates Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) with a Hold and announces $12 price target.

Initiation

Deutsche Bank Reinstates Hold on Dana, Announces $12 Price Target

Analysts' ratings for Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $14.0, a high estimate of $17.00, and a low estimate of $12.00. This current average has decreased by 2.78% from the previous average price target of $14.40. 
<img src="https://www.benzinga.com/files/images/story/2024/1725566488_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A clear picture of Dana's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$12.00</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Dana. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Dana compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Dana's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Dana's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DAN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Dana analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Dana</h2>
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.
<h3>Breaking Down Dana's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Dana's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.36%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Dana's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 0.58%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Dana's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.06%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Dana's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.2%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Dana's debt-to-equity ratio stands notably higher than the industry average, reaching 1.98. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 5 Analyst Recommendations For Dana

Wolfe Research analyst Emmanuel Rosner assumes Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) with a Peer Perform rating.

Wolfe Research Assumes Dana at Peer Perform

CVS Health, Apollo Global Management, And Novo Nordisk Reported Results

This week, several dividend stocks are trading close to their 52-week lows. Here is a list of ten such stocks that are also reaching their ex-divid...

Ex-Dividend Date Nearing for These 10 Stocks – Week of November 4, 2024

The great auto sector unwind: EV stocks fall while ICE suppliers and Ford gain

Ryan Brinkman, an analyst from J.P. Morgan, maintained the Buy rating on Dana Holding (DAN – Research Report). The associated price target was lowe...

Dana Holdings: Strong Operational Execution and Strategic Positioning Justify Buy Rating

Dana (DAN) is reaffirming its previously announced guidance ranges for sales of $10.2B-$10.4B, adjusted EBITDA of $855M-$895M and free cash flow of...

Dana backs FY24 revenue view $10.2B-$10.4B, consensus $10.38B

Dana (DAN) announced the appointment of R. Bruce McDonald, a member of the Dana Board of Directors, as Chairman and CEO, effective immediately. McD...

Dana names R. Bruce McDonald as CEO, effective immediately

Dana (DAN) announced it has engaged financial advisors Goldman Sachs & Co. and Morgan Stanley & Co. to sell its Off-Highway business, which the Boa...

Dana announces plans to sell Off-Highway business

While Dana (DAN) continues to improve its profitability in a challenging operating environment, the company announced further actions to support su...

Dana announces $200M cost reduction plan

Dana appoints new CEO, outlines cost saving measures

An announcement from Dana Holding ( ($DAN) ) is now available. Dana Incorporated has appointed R. Bruce McDonald as its new Chairman and CEO, succe...

Dana Holding Announces Leadership Change and Strategic Shift

AAPL

ABNB

ALSN

ANET

APTV

BLNK

CARZ

CBLL

CHPT

CPRI

CTVA

CVGW

DRIV

EVGO

FANG

FTNT

GILD

HMST

HSAI

ILMN

INVZ

MCHP

MELI

MSDL

MSFT

NXPI

PARA

PARAA

PHIN

PLOW

PLTR

PSNY

QCOM

QRVO

RACE

RDDT

SAVE

SKYQ

STFS

TTWO

VEEV

VRTX

WFRD

Press Releases

Reliance, Inc. Announces Appointment of James K. Kamsickas to Board of Directors and Douglas W. Stotlar as Chairman of the Board

Gabelli Funds to Host 48th Annual Automotive Symposium at The Encore at Wynn, Las Vegas, Nevada

Dana Incorporated Names Seth Metzger Chief Technology Officer

Dana Incorporated to Announce 2024 Third-quarter Financial Results, Host Conference Call and Webcast on Oct. 30

Dana Awarded Powertrain Product of the Year at Power Progress Summit 2024

Dividends

Dana to Pay Dividend on Common Stock

Dana Incorporated Reports 2024 Third-Quarter Financial Results, Reports Strong Third-Quarter Profit Margin, Maintains Full-Year Free Cash Flow Guidance

Dana Announces Leadership Transition and Actions to Accelerate Value Creation

DORM

GNTX

MNRO

MPAA

NNBR

ORLY

PRTS

RUSHA

STRT

Adient

Autoliv

Aptiv

American Axle & Manufacturing Holdings, Inc. Common Stock

American Axle & Mfg Hldgs

BorgWarner

Dorman Prods

ECARX Holdings Inc. - Class A Ordinary shares

ECARX Holdings

Fox Factory Hldg

Gentex

Garrett Motion

Holley

Hesai Group - American Depositary Share, each ADS represents one Class B ordinary share

Comments

Dana

Notizie

Ultime notizie per Dana (NYSE:DAN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO